As a protein involved in specific cellular signaling pathways, FAM179B activity can be modulated by a variety of chemical compounds that influence these pathways. For instance, compounds that elevate intracellular cyclic adenosine monophosphate (cAMP) levels are particularly effective in modulating FAM179B activity. This is achieved by activating adenylyl cyclase, which catalyzes the conversion of ATP to cAMP, a secondary messenger with a pivotal role in numerous signaling cascades. The rise in cAMP levels can thus lead to the activation of FAM179B through cAMP-dependent protein kinases. Moreover, beta-adrenergic agonists that also raise cAMP levels contribute to FAM179B activity by this mechanism. In a similar vein, the use of cell-permeable cAMP analogs further underscores the importance of cAMP-mediated signaling in the regulation of FAM179B.
In addition to cAMP-related mechanisms, there are other biochemical pathways that influence FAM179B activation. Certain activators of protein kinase C (PKC) are known to indirectly lead to FAM179B activation, as PKC plays a critical role in phosphorylation-driven cellular responses. Calcium signaling is another key regulator, with calcium ionophores inducing an increase in intracellular calcium levels, which can activate calcium-dependent signaling pathways involving FAM179B. Additionally, fluctuations in phosphorylation status caused by the inhibition of protein phosphatases or the influence of nitric oxide signaling can lead to the modulation of FAM179B activity. The inhibition of enzymes such as glycogen synthase kinase-3 further provides a means to alter signaling pathways that can result in the activation of FAM179B, showcasing the diversity of chemical interactions that can impact its activity within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A beta-adrenergic agonist that increases cAMP levels, potentially enhancing FAM179B activity through cAMP-mediated signaling cascades. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), which may phosphorylate and activate FAM179B as part of signal transduction processes. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
Acts as a signaling molecule that can modulate signal transduction pathways, potentially leading to the activation of FAM179B. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Increases intracellular calcium levels, which could activate calcium-dependent signaling pathways involving FAM179B. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
A calcium ionophore that raises intracellular calcium, potentially activating FAM179B through calcium-dependent mechanisms. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cell-permeable cAMP analog that activates cAMP-dependent pathways, possibly leading to increased FAM179B activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits protein phosphatases PP1 and PP2A, potentially increasing FAM179B phosphorylation and activation indirectly. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-selective inhibitor of phosphodiesterases, leading to an increase in cAMP levels, which may activate FAM179B through cAMP-dependent pathways. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits glycogen synthase kinase-3 (GSK-3), which may upregulate signaling pathways involving FAM179B activation. | ||||||